MDA-9 and GRP78 as potential diagnostic biomarkers for early detection of melanoma metastasis

Tumor Biology

Volumn 36, Issue 4, 2015, Pages 2973-2982

  Guan, Ming ^{a,b,c,d,e,f,g}   Chen, Xiaofan ^{a,b,c,d,e,f,g}   Ma, Yingyu ^{a,b,c,d,e,f,g}   Tang, Lihua ^{a,b,c,d,e,f,g}   Guan, Lei ^{a,b,c,d,e,f,g}   Ren, Xuefeng ^{a,b,c,d,e,f,g}   Yu, Bo ^{a,b,c,d,e,f,g}   Zhang, Wei ^{a,b,c,d,e,f,g}   Su, Bing ^{a,b,c,d,e,f,g}  

^a FUDAN UNIVERSITY   (China)

^b HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d PEKING UNIVERSITY SHENZHEN HOSPITAL   (China)

^e The 303rd Hospital of PLA   (China)

^f Skin Research Center of Guangzhou Landproof   (China)

^g UNIVERSITY AT BUFFALO   (United States)

Author keywords

Exosomes; GRP78; MDA 9; Melanoma; Two dimensional gel electrophoresis

Indexed keywords

HEAT SHOCK PROTEIN; MOLECULAR CHAPERONE GRP78; SDCBP PROTEIN, HUMAN; SYNTENIN; TUMOR MARKER;

BIOSYNTHESIS; DIAGNOSTIC USE; EARLY DIAGNOSIS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MELANOMA; NEOPLASM METASTASIS; PATHOLOGY; PROGNOSIS; PROTEOMICS;

EARLY DETECTION OF CANCER; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAT-SHOCK PROTEINS; HUMANS; MELANOMA; NEOPLASM METASTASIS; PROGNOSIS; PROTEOMICS; SYNTENINS; TUMOR MARKERS, BIOLOGICAL;

EID: 84936750868     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-2930-9     Document Type: Article

References (32)

1. Diepgen TL, Mahler V. The epidemiology of skin cancer. Br J Dermatol. 2002;146 Suppl 61:1–6.
2. Little EG, Eide MJ. Update on the current state of melanoma incidence. Dermatol Clin. 2012;30:355–61.
3. Balch CM, Sober AJ, Soong SJ, Gershenwald JE, Committee AMS. The new melanoma staging system. Semin Cutan Med Surg. 2003;22:42–54.
4. Berger MF, Levin JZ, Vijayendran K, Sivachenko A, Adiconis X, Maguire J, et al. Integrative analysis of the melanoma transcriptome. Genome Res. 2010;20:413–27.
5. Pleasance ED, Cheetham RK, Stephens PJ, McBride DJ, Humphray SJ, Greenman CD, et al. A comprehensive catalogue of somatic mutations from a human cancer genome. Nat. 2010;463:191–6.
6. Valenti R, Huber V, Filipazzi P, Pilla L, Sovena G, Villa A, et al. Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on t lymphocytes. Cancer Res. 2006;66:9290–8.
7. Andre F, Schartz NE, Movassagh M, Flament C, Pautier P, Morice P, et al. Malignant effusions and immunogenic tumour-derived exosomes. Lancet. 2002;360:295–305.
8. Vlassov AV, Magdaleno S, Setterquist R, Conrad R. Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim Biophys Acta. 1820;2012:940–8.
9. Xiao D, Ohlendorf J, Chen Y, Taylor DD, Rai SN, Waigel S, et al. Identifying mRNA, microRNA and protein profiles of melanoma exosomes. PLoS One. 2012;7:e46874.
10. Nicholas J. A new diagnostic tool with the potential to predict tumor metastasis. J Natl Cancer Inst. 2013;105:371–2.
11. Skog J, Wurdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, et al. Glioblastoma microvesicles transport rna and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008;10:1470–6.
12. Skokos D, Botros HG, Demeure C, Morin J, Peronet R, Birkenmeier G, et al. Mast cell-derived exosomes induce phenotypic and functional maturation of dendritic cells and elicit specific immune responses in vivo. J Immunol. 2003;170:3037–45.
13. Escola JM, Kleijmeer MJ, Stoorvogel W, Griffith JM, Yoshie O, Geuze HJ. Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. J Biol Chem. 1998;273:20121–7.
14. Wubbolts R, Leckie RS, Veenhuizen PT, Schwarzmann G, Mobius W, Hoernschemeyer J, et al. Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation. J Biol Chem. 2003;278:10963–72.
15. Nakayama T, Taback B, Turner R, Morton DL, Hoon DS. Molecular clonality of in-transit melanoma metastasis. Am J Pathol. 2001;158:1371–8.
16. Daigo Y, Chin SF, Gorringe KL, Bobrow LG, Ponder BA, Pharoah PD, et al. Degenerate oligonucleotide primed-polymerase chain reaction-based array comparative genomic hybridization for extensive amplicon profiling of breast cancers: a new approach for the molecular analysis of paraffin-embedded cancer tissue. Am J Pathol. 2001;158:1623–31.
17. Peinado H, Aleckovic M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through met. Nat Med. 2012;18:883–91.
18. Su B, Bu Y, Engelberg D, Gelman IH. Ssecks/gravin/akap12 inhibits cancer cell invasiveness and chemotaxis by suppressing a protein kinase C- Raf/MEK/ERK pathway. J Biol Chem. 2010;285:4578–86.
19. Hwangbo C, Kim J, Lee JJ, Lee JH. Activation of the integrin effector kinase focal adhesion kinase in cancer cells is regulated by crosstalk between protein kinase calpha and the pdz adapter protein mda-9/syntenin. Cancer Res. 2010;70:1645–55.
20. Boukerche H, Su ZZ, Prevot C, Sarkar D, Fisher PB. Mda-9/syntenin promotes metastasis in human melanoma cells by activating c-src. Proc Natl Acad Sci U S A. 2008;105:15914–9.
21. Papalas JA, Vollmer RT, Gonzalez-Gronow M, Pizzo SV, Burchette J, Youens KE, et al. Patterns of grp78 and mtj1 expression in primary cutaneous malignant melanoma. Mod Pathol: Off J U S Can Acad Pathol Inc. 2010;23:134–43.
22. Zhuang L, Scolyer RA, Lee CS, McCarthy SW, Cooper WA, Zhang XD, et al. Expression of glucose-regulated stress protein grp78 is related to progression of melanoma. Histopathol. 2009;54:462–70.
23. Selim MA, Burchette JL, Bowers EV, de Ridder GG, Mo L, Pizzo SV, et al. Changes in oligosaccharide chains of autoantibodies to grp78 expressed during progression of malignant melanoma stimulate melanoma cell growth and survival. Melanoma Res. 2011;21:323–34.
24. Vandenbroeck K, Alloza I, Brehmer D, Billiau A, Proost P, McFerran N, et al. The conserved helix c region in the superfamily of interferon-gamma /interleukin-10-related cytokines corresponds to a high-affinity binding site for the hsp70 chaperone dnak. J Biol Chem. 2002;277:25668–76.
25. Huang SK, Darfler MM, Nicholl MB, You J, Bemis KG, Tegeler TJ, et al. Lc/ms-based quantitative proteomic analysis of paraffin-embedded archival melanomas reveals potential proteomic biomarkers associated with metastasis. PLoS One. 2009;4:e4430.
26. Hardesty WM, Kelley MC, Mi D, Low RL, Caprioli RM. Protein signatures for survival and recurrence in metastatic melanoma. J Proteome. 2011;74:1002–14.
27. Wang P, Bouwman FG, Mariman EC. Generally detected proteins in comparative proteomics—a matter of cellular stress response? Proteome. 2009;9:2955–66.
28. Boukerche H, Su ZZ, Emdad L, Baril P, Balme B, Thomas L, et al. Mda-9/syntenin: a positive regulator of melanoma metastasis. Cancer Res. 2005;65:10901–11.
29. Gangemi R, Mirisola V, Barisione G, Fabbi M, Brizzolara A, Lanza F, et al. Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progression. PLoS One. 2012;7:e29989.
30. Fernandez-Larrea J, Merlos-Suarez A, Urena JM, Baselga J, Arribas J. A role for a pdz protein in the early secretory pathway for the targeting of protgf-alpha to the cell surface. Mol Cell. 1999;3:423–33.
31. Misra UK, Gonzalez-Gronow M, Gawdi G, Wang F, Pizzo SV. A novel receptor function for the heat shock protein grp78: silencing of grp78 gene expression attenuates alpha2m*-induced signalling. Cell Signal. 2004;16:929–38.
32. Misra UK, Deedwania R, Pizzo SV. Binding of activated alpha2-macroglobulin to its cell surface receptor grp78 in 1-ln prostate cancer cells regulates pak-2-dependent activation of limk. J Biol Chem. 2005;280:26278–86.